Rich Nations Seek to Gain Bulk of Future Covid-19 Vaccine - Study

A new global assessment of purchasing agreements for Covid-19 vaccines reveals that high-income countries, as well as a few middle-income countries flush with manufacturing capacity, have already purchased nearly 3.8 billion doses, with options for another five billion. The analysis, released by the Duke Global Health Innovation Center, shows that many of these countries will be able to vaccinate their entire populations-and some many times over-before billions of people are vaccinated in low-income countries. While other assessments have warned of potential inequalities in vaccine access, this new analysis is the first to carefully quantify the amount of vaccine doses that are being claimed by country-level agreements and how this could delay access to Covid-19 protection across large regions - including sub-Saharan Africa - until almost the middle of the decade.


A medical scientist works on testing of the novel coronavirus.

AllAfrica publishes around 800 reports a day from more than 110 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.